CASP1 and colitis: This molecule has demonstrated an inhibitory effect against the NLRP3 signaling pathway, decreasing the protein levels of NLRP3, ASC, caspase-1 p45, and caspase-1 p20 in the colon tissue of BALB/c mice with induced colitis [59].